Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis-Reference-Cited by-同舟云学术

Lopinavir-Ritonavir Monotherapy Versus Lopinavir-Ritonavir and 2 Nucleosides for Maintenance Therapy of HIV: 96-Week Analysis

Published:2009-06 Issue:2 Volume:51 Page:147-152
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Arribas Jose R,Delgado Rafael,Arranz Alberto,Muñoz Rosa,Portilla Joaquin,Pasquau Juan,Pérez-Elias María J,Iribarren Jose A,Rubio Rafael,Ocampo Antonio,Sánchez-Conde Matilde,Knobel Hernando,Arazo Piedad,Sanz Jesús,López-Aldeguer José,Montes María L,Pulido Federico

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference8 articles.

1. Lopinavir-ritonavir as single-drug therapy for maintenance of HIV-1 viral suppression: 48-week results of a randomized, controlled, open-label, proof-of-concept, pilot clinical trial (OK Study).;Arribas;J Acquir Immune Defic Syndr,2005

2. Lopinavir-ritonavir monotherapy versus lopinavir-ritonavir and two nucleosides for maintenance therapy of HIV.;Pulido;AIDS,2008

3. Ninety-six week results of a randomized comparative trial of lopinavir/ritonavir plus lamivudine/zidovudine followed by deintensification to lopinavir/ritonavir monotherapy versus efavirenz plus lamivudine/zidovudine therapy in antiretroviral-naive subject.;Cameron;J Infect Dis,2008

4. Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.;Delfraissy;AIDS,2008

5. Analisis farmacoeconomico de una estrategia de mantenimiento con lopinavir-ritonavir como monoterapia en pacientes con infeccion por el VIH.;Escobar;Enferm Infecc Microbiol Clin,2006

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. THERAPEUTIC STRATEGIES AND USE OF LOPINAVIR/RITONAVIR IN PATIENTS WITH HIGHLY RESISTANT HUMAN IMMUNODEFICIENCY VIRUS;FARMACIA;2024

2. Long-term efficacy and safety of a treatment strategy for HIV infection using protease inhibitor monotherapy: 8-year routine clinical care follow-up from a randomised, controlled, open-label pragmatic trial (PIVOT);eClinicalMedicine;2024-03

3. BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022;HIV Medicine;2022-12

4. Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected Patient;Clinical Drug Investigation;2019-08-10

5. Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study);BMC Infectious Diseases;2019-02-28